EUVIMEDEUVIMED entdecken
Open Access

The effects of switching from etelcalcetide to upacicalcet in hemodialysis patients with secondary hyperparathyroidism

Eiichi Sato, Miyako Urata, Shohei Sato, Takao Ono, Manaka Degawa, Hongmei Lu, Mayumi Nomura, Daisuke Matsumura, Noriaki Moriyama, Mayuko Amaha, Tsukasa Nakamura

Clinical Nephrology · 2025

DOI: 10.5414/cn111695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nephrology, 2025. Verfasst von Eiichi Sato und 10 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyperparathyroidism, Secondary, Renal Dialysis, Calcimimetic Agents, Peptides. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, SecondaryRenal DialysisCalcimimetic AgentsPeptidesDrug SubstitutionHumansMaleFemaleRetrospective StudiesMiddle AgedAgedParathyroid HormonePhosphorusCalciumJapanTreatment OutcomeBiomarkersCalcitriolPropionates

Substanzen

etelcalcetide hydrochlorideParathyroid HormoneCalcimimetic AgentsPhosphorusPeptidesCalciumBiomarkersmaxacalcitolupacicalcetCalcitriol

Zitieren

APA

Sato, E., Urata, M., Sato, S., Ono, T., Degawa, M., Lu, H., Nomura, M., Matsumura, D., Moriyama, N., Amaha, M., & Nakamura, T. (2025). The effects of switching from etelcalcetide to upacicalcet in hemodialysis patients with secondary hyperparathyroidism. Clinical Nephrology. https://doi.org/10.5414/cn111695

Vancouver

Sato E, Urata M, Sato S, Ono T, Degawa M, Lu H, et al. The effects of switching from etelcalcetide to upacicalcet in hemodialysis patients with secondary hyperparathyroidism. Clinical Nephrology. 2025. doi:10.5414/cn111695

BibTeX
@article{Sato2025,
  author = {Sato, Eiichi and Urata, Miyako and Sato, Shohei and Ono, Takao and Degawa, Manaka and Lu, Hongmei and Nomura, Mayumi and Matsumura, Daisuke and Moriyama, Noriaki and Amaha, Mayuko and Nakamura, Tsukasa},
  title = {The effects of switching from etelcalcetide to upacicalcet in hemodialysis patients with secondary hyperparathyroidism},
  journal = {Clinical Nephrology},
  year = {2025},
  doi = {10.5414/cn111695}
}
Kostenlos starten →